People > Dr. Wang Yifei

Dr. Wang Yifei

Co-Manager, Equitile GL Longevity Fund

Dr. Wang Yifei is Co-Manager of the Longevity Fund and a seasoned investment professional with deep expertise in healthcare and life sciences.

Wang brings nearly two decades of experience spanning investment management, equity research, and financial advisory. While managing the Equitile GL Longevity Fund, he is a Partner at GL Capital Group, a healthcare-focused investment firm managing $3.5 billion in assets. Before that, he was a Fund Manager and Equity Analyst at Columbia Threadneedle Investments, and an Equity Analyst at Goldman Sachs, focusing on European pharmaceutical and biotechnology companies.

Wang holds a PhD in Biomedical Sciences from University of Sheffield, where he was awarded a Cancer Research UK Scholarship. He also earned a BSc in Biological Sciences from Fudan University.

As Co-Manager of the Longevity Fund, Wang oversees healthcare investment strategies, leveraging his scientific and financial acumen to identify transformative opportunities in biotechnology, pharmaceuticals, and longevity research. Passionate about bridging science and capital, he is dedicated to advancing innovations that extend healthspan and improve quality of life.

Risk Warning

The value of investments and the income from them can go down as well as up and investors may not get back the amount originally invested and may lose all of their investment. The value of investments in the investment funds contained on this website may be affected by the price of underlying investments. Exchange rate changes may cause the value of overseas investments to rise or fall.

Nothing contained on this website constitutes, and nothing on this website should be construed as, investment advice or a recommendation to buy, sell, hold or otherwise transact in any investment. It is strongly recommended that you seek professional investment advice before making any investment decision.

You should consider whether an investment fits your investment objectives, particular needs and financial situation before making any investment decision. You should also inform yourself and seek advice as to (a) the possible tax consequences, (b) the legal requirements and (c) any foreign exchange restrictions or exchange control requirements which you might encounter under the laws of the countries of your citizenship, residence or domicile and which might be relevant to the subscription, holding, transfer or disposal of interests in any investment fund.

To the extent that this website contains any information regarding the past performance and/or forecast of investment funds, such information is not a reliable indicator of future performance of these investment funds and should not be relied upon as a basis for an investment decision

Equitile Investments Ltd (“Equitile”) offers no guarantee against loss or that investment objectives will be achieved. Please read the Key Investor Information Document, Prospectus and any other offer documents carefully and consult with your own legal, accounting, tax and other advisors in order to independently assess the merits of an investment.

Equitile Investments Ltd is authorised and regulated by the Financial Conduct Authority in the United Kingdom and is a company registered in England, number: 09459099. Registered Office: 2nd Floor, Regis House, 45 King William Street, London EC4R 9AN.

By clicking “Accept” you confirm that you have read and understood the above information.

Dr. Wang Yifei

Investment Platforms

Risk Warning

Register

Register